Page last updated: 2024-09-03

troxacitabine and Leukemia, T-Cell

troxacitabine has been researched along with Leukemia, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernier, L; Bibeau, L; Bowlin, T; Custeau, D; Gourdeau, H; Ouellet, F	1

Other Studies

1 other study(ies) available for troxacitabine and Leukemia, T-Cell

Article	Year
Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity. Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Division; Cytidine Deaminase; Cytosine; Dioxolanes; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Leukemia, T-Cell; Mice; Mice, SCID; Transplantation, Heterologous; Tumor Cells, Cultured	2001

Article

Year

Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.

Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:3

Topics: Animals; Antineoplastic Agents; Cell Division; Cytidine Deaminase; Cytosine; Dioxolanes; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Leukemia, T-Cell; Mice; Mice, SCID; Transplantation, Heterologous; Tumor Cells, Cultured

2001